Diagnosis of Shigella dysenteriae

作者: Alf A. Lindberg , Karl-Anders Karlsson

DOI:

关键词:

摘要: A composition for therapeutic or diagnostic use in connection with the toxine of Shigella dysenteriae. As an active constituent contains consists a compound having formula (I): ##STR1## wherein R1 is hydrogen organic residue, and R2 hydrogen, alkyl, alkoxi carbohydric residue proviso that not β-D-GalNacp-(1-0) when D-Glc -β-D-Glcp-(1-0)-ceramide different from OH, α-D-GalNAcp-(1-3)-β-D-GalNAcp-(1-0)-, β-D-GalNAcp-(1-3)-β-D-GalNAcp-(-0)-, α-L-Fucp-(1-2)-β-D-Galp-(1-3)-β-D-GalNAcp-(1-0)- α-L-Fucp-(1-2)-α-D-Galp-(1-3)-(1-0)-; method treatment; treatment diagnosis.

参考文章(5)
S. Olsnes, K. Eiklid, Isolation and characterization of Shigella shigae cytotoxin. Journal of Biological Chemistry. ,vol. 255, pp. 284- 289 ,(1980) , 10.1016/S0021-9258(19)86295-6
J. Edward Brown, Darrell E. Griffin, Sara W. Rothman, B. P. Doctor, Purification and Biological Characterization of Shiga Toxin from Shigella dysenteriae 1 Infection and Immunity. ,vol. 36, pp. 996- 1005 ,(1982) , 10.1128/IAI.36.3.996-1005.1982
David G Marsh, Michael J Crutchley, Method for the purification of lipopolysaccharides ,(1967)